Plain-English translation of NCT05061550 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing seven different combinations of new medications—including drugs like , , , and others—given before and after surgery for people with early-stage non-small cell lung cancer. The goal is to help your immune system fight the cancer before surgery removes the tumor, and then continue protecting you afterward. Researchers want to find which combination works best and is safest.
Currently, people with early-stage lung cancer that can be surgically removed have limited treatment options beyond surgery alone. This medication is designed to boost your immune system to attack cancer cells before they're removed, which may help prevent the cancer from returning.
You likely qualify if…
You likely don't qualify if…
You would receive the assigned medication combination in hospital or clinic visits before surgery, then have surgery to remove the tumor, and then continue receiving the medication afterward. The exact schedule depends on which of the seven treatment arms you're randomly assigned to, but generally involves multiple infusions or doses of the new medications over several months. You'll have regular blood tests, scans, and check-ins to monitor how well the treatment is working and how you're tolerating it.
AI-generated summary from trial data · Aug 4, 2026 · Not medical advice
United States